Acute stroke: Shifting from informed consent to informed refusal of intravenous tissue-type plasminogen activator

Circulation: Cardiovascular Quality and Outcomes

Volumn 8, Issue 6_suppl_3, 2015, Pages S69-S72

  Schwamm, Lee H ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

decision making; Editorials; health services research; thrombolytic therapy; tissue plasminogen activator

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR;

ACUTE HEART INFARCTION; BLEEDING; BLOOD CLOT LYSIS; CEREBROVASCULAR ACCIDENT; DECISION MAKING; EMERGENCY TREATMENT; FIBRINOLYTIC THERAPY; HEART ARREST; HUMAN; INFORMED CONSENT; INTERVIEW; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REVIEW; RISK FACTOR; TREATMENT REFUSAL; BRAIN ISCHEMIA; DECISION SUPPORT SYSTEM; FEMALE; MALE; STROKE;

BRAIN ISCHEMIA; DECISION SUPPORT TECHNIQUES; FEMALE; HUMANS; MALE; STROKE;

EID: 84945951340     PISSN: 19417713     EISSN: 19417705     Source Type: Journal    
DOI: 10.1161/CIRCOUTCOMES.115.002282     Document Type: Review

References (20)

1. Decker C, Chhatriwalla E, Gialde E, Garavalia B, Summers D, Quinlan M, Cheng E, Rymer M, Saver JL, Chen E, Kent DM, Spertus JA, Patient-centered decision support in acute ischemic stroke: qualitative study of patients' and providers' perspectives. Circ Cardiovasc Qual Outcomes 2015 8 S109 S116. doi: 10.1161/CIRCOUTCOMES.115.002003
2. Brown M, Clinical Policy: Use of Intravenous Tissue Plasminogen Activator for the Management of Acute Ischemic Stroke in the Emergency Department 2015. http://www.acep.org/workarea/DownloadAsset.aspx?id=102612. Accessed June 13, 2015
3. Saver JL, Time is brain-quantified. Stroke 2006 37 263 266. doi: 10.1161/01.STR.0000196957.55928.ab
4. Thomas L, Viswanathan A, Cochrane TI, Johnson J, O'Brien J, McMahon M, Santimauro JM, Schwamm LH, Variability in the perception of informed consent for IV-tPA during telestroke consultation. Front Neurol 2012 3 128. doi: 10.3389/fneur.2012.00128
5. Veroff D, Marr A, Wennberg DE, Enhanced support for shared decision making reduced costs of care for patients with preference-sensitive conditions. Health Aff (Millwood) 2013 32 285 293. doi: 10.1377/hlthaff.2011.0941
6. Knox R, Doctor Writes His Own Prescription 2009. http://www.npr.org/sections/health-shots/2009/12/doctor-writes-his-own-prescrip.html. Accessed June 13, 2015
7. Bhatt A, Safdar A, Chaudhari D, Clark D, Pollak A, Majid A, Kassab M, Medicolegal considerations with intravenous tissue plasminogen activator in stroke: a systematic review. Stroke Res Treat 2013 2013 562564. doi: 10.1155/2013/562564
8. Grotta JC, Hacke W, Stroke neurologist's perspective on the new endovascular trials. Stroke 2015 46 1447 1452. doi: 10.1161/STROKEAHA.115.008384
9. Lansberg MG, Schrooten M, Bluhmki E, Thijs VN, Saver JL, Treatment time-specific number needed to treat estimates for tissue plasminogen activator therapy in acute stroke based on shifts over the entire range of the modified Rankin Scale. Stroke 2009 40 2079 2084. doi: 10.1161/STROKEAHA.108.540708
10. Fonarow GC, Zhao X, Smith EE, Saver JL, Reeves MJ, Bhatt DL, Xian Y, Hernandez AF, Peterson ED, Schwamm LH, Door-to-needle times for tissue plasminogen activator administration and clinical outcomes in acute ischemic stroke before and after a quality improvement initiative. JAMA 2014 311 1632 1640. doi: 10.1001/jama.2014.3203
11. Smith EE, Fonarow GC, Reeves MJ, Cox M, Olson DM, Hernandez AF, Schwamm LH, Outcomes in mild or rapidly improving stroke not treated with intravenous recombinant tissue-type plasminogen activator: findings from Get With The Guidelines-Stroke. Stroke 2011 42 3110 3115. doi: 10.1161/STROKEAHA.111.613208
12. Menon BK, Saver JL, Prabhakaran S, Reeves M, Liang L, Olson DM, Peterson ED, Hernandez AF, Fonarow GC, Schwamm LH, Smith EE, Risk score for intracranial hemorrhage in patients with acute ischemic stroke treated with intravenous tissue-type plasminogen activator. Stroke 2012 43 2293 2299. doi: 10.1161/STROKEAHA.112.660415
13. Smith EE, Shobha N, Dai D, Olson DM, Reeves MJ, Saver JL, Hernandez AF, Peterson ED, Fonarow GC, Schwamm LH, Risk score for in-hospital ischemic stroke mortality derived and validated within the Get With the Guidelines-Stroke Program. Circulation 2010 122 1496 1504. doi: 10.1161/CIRCULATIONAHA.109.932822
14. Chiong W, Kim AS, Huang IA, Farahany NA, Josephson SA, Testing the presumption of consent to emergency treatment for acute ischemic stroke. JAMA 2014 311 1689 1691. doi: 10.1001/jama.2014.3302
15. Rubin EB, Bernat JL, Consent issues in neurology. Neurol Clin 2010 28 459 473. doi: 10.1016/j.ncl.2009.11.007
16. Chiong W, Kim AS, Huang IA, Farahany NA, Josephson SA, Inability to consent does not diminish the desirability of stroke thrombolysis. Ann Neurol 2014 76 296 304. doi: 10.1002/ana.24209
17. Jauch EC, Saver JL, Adams HP Jr, Bruno A, Connors JJ, Demaerschalk BM, Khatri P, McMullan PW Jr, Qureshi AI, Rosenfield K, Scott PA, Summers DR, Wang DZ, Wintermark M, Yonas H, American Heart Association Stroke Council; Council on Cardiovascular Nursing; Council on Peripheral Vascular Disease; Council on Clinical Cardiology Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2013 44 870 947. doi: 10.1161/STR.0b013e318284056a
18. American Academy of Neurology Policy on Consent Issues for the Administration of IV tPA 2011. https://www.aan.com/uploadedFiles/Website-Library-Assets/Documents/6.Public-Policy/1.Stay-Informed/2.Position-Statements/3.PDFs-of-all-Position-Statements/IV.pdf. Accessed June 13, 2015
19. Food and Drug Administration Exception From Informed Consent Requirements for Emergency Research 2013. (http://www.fda.gov/downloads/RegulatoryInformation/Guidances/UCM249673.pdf). Accessed June, 13, 2015
20. Schwamm LH, Holloway RG, Amarenco P, Audebert HJ, Bakas T, Chumbler NR, Handschu R, Jauch EC, Knight WA 4th, Levine SR, Mayberg M, Meyer BC, Meyers PM, Skalabrin E, Wechsler LR, American Heart Association Stroke Council; Interdisciplinary Council on Peripheral Vascular Disease A review of the evidence for the use of telemedicine within stroke systems of care: a scientific statement from the American Heart Association/American Stroke Association. Stroke 2009 40 2616 2634. doi: 10.1161/STROKEAHA.109.192360